Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated With Percutaneous Ablation and Palliative Radiation Therapy

NCT06859801 is registered in ClinicalTrials.gov with Society of Interventional Oncology as lead sponsor.

NCT NCT06859801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06859801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated With Percutaneous Ablation and Palliative Radiation Therapy
Lead sponsor
Society of Interventional Oncology
Phase
Observational
Overall status
Recruiting
Start date
October 23, 2025
Completion date
July 31, 2027
Enrollment
120 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

bone cancer metastatic